Code | 89245 | ||||||||||
MA number | EU/1/95/002/005 | ||||||||||
Product Form: | con inf 1x8 ml/160 mg (liek.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application |
MA issued: | 27.04.2010 |
SmPC + PL: | European Medicines Agency's database |
Dokument: | DHPC Taxotere (docetaxel) 5 12 2011.pdf |
Dokument: | DHPC Taxotere_01 12 2011.doc |
Safety feature | No |
Data update: | 24.01.2020 |